Simultaneously, FGF-23 suppresses the activity of renal 1α-hydroxylase and promotes the activity of 24-hydroxylase, leading to insufficient active vitamin D and reduced intestinal phosphate absorption, further exacerbating hypophosphatemia. The gene discussed is FGF23; the disease is hypophosphatemia.